QCM
RCKT icon

Quantinno Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Quantinno Capital Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$132K Sell
38,680
-37,568
-49% -$125K ﹤0.01% 3370
2026
Q1 		$273K Buy
76,248
+35,851
+89% +$142K ﹤0.01% 3076
2025
Q4 		$142K Buy
+40,397
New +$138K ﹤0.01% 3103
2025
Q1 		– Sell
-12,014
Closed -$151K – 2137
2024
Q4 		$151K Buy
+12,014
New +$181K ﹤0.01% 1575

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Quantinno Capital Management's RCKT Position: Q2 2026 in Review

Quantinno Capital Management reduced its Rocket Pharmaceuticals (RCKT) stake by 49% in Q2 2026, selling an estimated $125K and leaving 38,680 shares worth $132K. The position accounts for ﹤0.01% of the portfolio, ranked #3370.

Quantinno Capital Management first reported a position in RCKT in Q4 2024 and has held it in 4 quarters since. The position peaked at $273K in Q1 2026. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Quantinno Capital Management held 38,680 shares of Rocket Pharmaceuticals worth $132K as of Q2 2026.
  • Quantinno Capital Management sold 37,568 Rocket Pharmaceuticals shares in Q2 2026, an estimated $125K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #3370 holding.
  • Quantinno Capital Management first reported a position in Rocket Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • Quantinno Capital Management's Rocket Pharmaceuticals position peaked at $273K in Q1 2026.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.